With more than 5 years of experience in evidence reviews, data synthesis, and academic research, Lamees has played a key role in developing evidence-based strategies across various therapeutic areas, including cardiovascular, respiratory, neurology, oncology, and other medical fields.
At Stratenym, she specializes in evaluating evidence, conducting PRISMA-guided systematic literature reviews and targeted literature reviews. Prior to joining Stratenym, Lamees supported the development of value dossiers, indirect treatment comparisons, cost-effectiveness and budget impact models, and manuscripts. With her strong foundation, Lamees integrates patient-centric perspectives with an understanding of clinical and economic data to advance healthcare delivery and improve access to innovative therapies worldwide.